# The Aerobic Exercise Capacity and Muscle Strenght in Individuals With COVID-19

> **NCT06272266** · NA · COMPLETED · sponsor: **Selda Sarıkaya** · enrollment: 41 (actual)

## Conditions studied

- COVID-19 Pneumonia
- COVID-19

## Interventions

- **DEVICE:** Kardiopulmonary exercise test (Quark KPET C12x/T12x device connected to the Omnia version 1.6.8 COSMED system)
- **DEVICE:** Peripheral muscle strength measurement (microFET3 (Hoggan Health Industries, Fabrication Enterprises, lnc) and JAMAR hydraulic hand dynamometer (Sammons Preston, Rolyon, Bolingbrook).
- **DEVICE:** Standard exercise tolerance test (a bicycle ergometer and recorded through the ergoline rehabilitation system 2 Version 1.08 SPI.)
- **DEVICE:** Aerobic exercise training (a bicycle ergometer and recorded through the ergoline rehabilitation system 2 Version 1.08 SPI.)

## Key facts

- **NCT ID:** NCT06272266
- **Lead sponsor:** Selda Sarıkaya
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-20
- **Primary completion:** 2022-05-30
- **Final completion:** 2023-02-15
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2024-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06272266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06272266, "The Aerobic Exercise Capacity and Muscle Strenght in Individuals With COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06272266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*